Abiogen And mAbxience Join Forces In Italy

Firms Partner On Undisclosed Biosimilar For Italian Market

 
• By Dave Wallace

Spanish biosimilars developer mAbxience has struck a deal with Italy’s Abiogen covering an undisclosed biosimilar for the Italian market.

Spain’s mAbxience has allied with Italy’s Abiogen (Shutterstock)

More from Deals

More from Products